A nurse is collecting data from client who has just begun therapy with alprazolam to treat anxiety. The nurse should observe the client for which of the following adverse effects of this medication?
Hypertension
Hearing loss
Sedation
Bradycardia
The Correct Answer is C
A. Alprazolam, a benzodiazepine, typically doesn't cause hypertension. Its primary mechanism of action involves modulation of GABA receptors in the central nervous system, leading to anxiolytic effects rather than effects on blood pressure regulation.
B. There's no documented association between alprazolam use and hearing loss.
Benzodiazepines like alprazolam primarily affect the central nervous system and do not target auditory structures.
C. Sedation is a common side effect of alprazolam due to its CNS depressant properties.
Patients often experience drowsiness, fatigue, and impaired cognitive function, especially when initiating therapy or when doses are increased.
D. Alprazolam typically doesn't cause bradycardia. While it can have mild effects on heart rate, such as tachycardia, significant bradycardia is not a documented adverse effect.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
A. Methylergonovine is not indicated for preventing postpartum infections. Its primary action is on uterine smooth muscle to induce contractions, rather than having antimicrobial properties.
B. While methylergonovine can cause hypertension as a side effect, it's not used to prevent hypertension. It is used primarily to prevent or treat postpartum hemorrhage by promoting uterine contraction.
C. Methylergonovine is a uterotonic medication used to prevent or treat postpartum hemorrhage by causing uterine contractions, thereby reducing the risk of excessive bleeding after childbirth.
D. Methylergonovine does not prevent thromboembolic events; its mechanism of action primarily involves stimulation of uterine smooth muscle contraction rather than affecting blood coagulation.
Correct Answer is A
Explanation
A. A lithium level of 1.2 mEq/L falls within the therapeutic range (0.6-1.2 mEq/L) for the treatment of bipolar disorder. Therefore, the nurse should administer the regular dose of lithium as prescribed and closely monitor the client for any side effects.
B. Repeating the lithium level is unnecessary because the current level is within the therapeutic range. Repeated testing may be warranted if the level is outside the therapeutic range or if there are clinical concerns.
C. This action is not indicated for a lithium level within the therapeutic range. ECG and seizure precautions are typically reserved for lithium toxicity, which presents with levels above the therapeutic range.
D. Increasing the dose of lithium is not warranted when the current level is within the therapeutic range. Doing so could increase the risk of toxicity.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.